The current review highlights the evidence supporting the use of ketogenic diet therapies in the management of adult epilepsy, adult malignant glioma and Alzheimer's disease. An overview of the scientific literature, both preclinical and clinical, in each area is presented and management strategies for addressing adverse effects and compliance are discussed.
Keywords: Alzheimer’s disease; epilepsy; glioblastoma multiforme; malignant glioma; modified Atkins diet.